SEC Form 4 · accession 0001179110-15-013515
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramesh Kumar
Officer — President and CEO · Director
Period of report
Sep 25, 2015
Accepted (ET)
Oct 1, 2015 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $1.48 | Sep 25, 2015 | A | 87,500 | A | — | Sep 25, 2025 | Common Stock | 87,500 | 87,500 | D |
Explanation of responses
- F1These options vest over four years in 48 equal monthly installments.